Latest filing published 22 Mar 2010 for Ernexa Therapeutics Inc., €41k.
Insider track record
No signal scores available.
Terry Allan Bateman: trading record in brief
Terry Allan Bateman appears in our data through filings on Ernexa Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 26 June 2009 to 19 March 2010, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 22 March 2010, reports an option exercise of €41k in Ernexa Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Terry Allan Bateman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 328,125 shares@ US$0.17Common StockSEC:0001019687-10-001063:0
- 145,833 shares@ US$0.17Common StockSEC:0001019687-09-002354:0
- 30,000 shares@ US$0.12Common StockSEC:0001019687-09-002354:1
3 of 3 declarations
